Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview
Open accessThe DOI matches its Crossref record; 244 of the 244 references it cites were found in a registry or an index.
Abstract
Interleukin-23 (IL-23) is a pro-inflammatory cytokine composed of two subunits, IL-23A (p19) and IL-12/23B (p40), the latter shared with Interleukin-12 (IL-12). IL-23 is mainly produced by macrophages and dendritic cells, in response to exogenous or endogenous signals, and drives the differentiation and activation of T helper 17 (Th17) cells with subsequent production of IL-17A, IL-17F, IL-6, IL-22, and tumor necrosis factor α (TNF-α). Although IL-23 plays a pivotal role in the protective immune response to bacterial and fungal infections, its dysregulation has been shown to exacerbate chronic immune-mediated inflammation. Well-established experimental data support the concept that IL-23/IL-17 axis activation contributes to the development of several inflammatory diseases, such as PsA, Psoriasis, Psoriatic Arthritis; AS, Ankylosing Spondylitis; IBD, Inflammatory Bowel Disease; RA, Rheumatoid Arthritis; SS, Sjogren Syndrome; MS, Multiple Sclerosis. As a result, emerging clinical studies have focused on the blockade of this pathogenic axis as a promising therapeutic target in several autoimmune disorders; nevertheless, a greater understanding of its contribution still requires further investigation. This review aims to elucidate the most recent studies and literature data on the pathogenetic role of IL-23 and Th17 cells in inflammatory rheumatic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
Interferon-γ: an overview of signals, mechanisms and functions
Schroder, K., Hertzog, P. J., Ravasi, T., & Hume, D. A. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0603252 · Cited by 4,120
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099 · cited 2×
“Although IL-23 has mainly been identified as the initiating factor for IL-17 expression from T cells (9, 46), Th0 cells do not constitutively express IL-23R, but they are still sensitive to IL23 (47); in this context, it is reasonable to assume that IL-23R expression on these cells can be induced in the presence of ot…”
BackgroundInterleukin-12 and the regulation of innate resistance and adaptive immunity
Trinchieri, G. (2003) · Nature Reviews Immunology · doi:10.1038/nri1001 · Cited by 3,927
Rudwaleit, M., van der Heijde, D., Landewé, R., Listing, J., Akkoc, N., Brandt, J., Braun, J., Chou, C. T., Collantes-Estevez, E., Dougados, M., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.108233 · Cited by 3,690
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605 · cited 1×
“IL-6 promotes Th17 differentiation by inhibiting T reg generation (51), while IL-2 acts in the opposite way (236).”
BackgroundTransforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087
Atopic Dermatitis: Global Epidemiology and Risk Factors
Nutten, S. (2015) · Annals of Nutrition and Metabolism · doi:10.1159/000370220 · Cited by 3,055
Scott, D. L., Wolfe, F., & Huizinga, T. W. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60826-4 · Cited by 3,013
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Oppmann, B., Lesley, R., Blom, B., Timans, J. C., Xu, Y., Hunte, B., Vega, F., Yu, N., Wang, J., Singh, K., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00070-4 · Cited by 2,822
Cytokines in the pathogenesis of rheumatoid arthritis
McInnes, I. B., & Schett, G. (2007) · Nature Reviews Immunology · doi:10.1038/nri2094 · Cited by 2,529
Liang, S. C., Tan, X.-Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M., & Fouser, L. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061308 · Cited by 2,330 · cited 2×
“Synergism between IL-17 and TNF-α has been shown to activate the production of pro-inflammatory mediators, such as IL-1β, IL-6, IL-8, PGE2, and matrix metalloproteinases (MMPs), promoting progression of early inflammation toward a chronic arthritis (205, 206).”
BackgroundZhou, L., Ivanov, I. I., Spolski, R., Min, R., Shenderov, K., Egawa, T., Levy, D. E., Leonard, W. J., & Littman, D. R. (2007) · Nature Immunology · doi:10.1038/ni1488 · Cited by 2,141
Development, cytokine profile and function of human interleukin 17-producing helper T cells
Wilson, N. J., Boniface, K., Chan, J. R., McKenzie, B. S., Blumenschein, W. M., Mattson, J. D., Basham, B., Smith, K., Chen, T., Morel, F., et al. (2007) · Nature Immunology · doi:10.1038/ni1497 · Cited by 2,035
Endogenous Antimicrobial Peptides and Skin Infections in Atopic Dermatitis
Ong, P. Y., Ohtake, T., Brandt, C., Strickland, I., Boguniewicz, M., Ganz, T., Gallo, R. L., & Leung, D. Y. M. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021481 · Cited by 1,960 · cited 1×
“In skin lesions IL-22 drives keratinocyte hyperproliferation via STAT3 signaling (177) and prompts epithelial cells to release chemokines, such as IL-8 (178, 179), a key factor in neutrophil recruitment in psoriatic lesions and stimulates keratinocytes to secrete antimicrobial peptides (180, 181), preventing skin lesi…”
BackgroundAcosta-Rodriguez, E. V., Napolitani, G., Lanzavecchia, A., & Sallusto, F. (2007) · Nature Immunology · doi:10.1038/ni1496 · Cited by 1,857
IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells
Korn, T., Bettelli, E., Gao, W., Awasthi, A., Jäger, A., Strom, T. B., Oukka, M., & Kuchroo, V. K. (2007) · Nature · doi:10.1038/nature05970 · Cited by 1,848
Aggarwal, S., Ghilardi, N., Xie, M.-H., de Sauvage, F. J., & Gurney, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207577200 · Cited by 1,847
IL-17 family cytokines and the expanding diversity of effector T cell lineages
Weaver, C. T., Hatton, R. D., Mangan, P. R., & Harrington, L. E. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141557 · Cited by 1,842 · cited 7×
“IL-23 is mainly produced by macrophages and dendritic cells, in response to exogenous or endogenous signals, and drives the differentiation and activation of T helper 17 (Th17) cells with subsequent production of IL-17A, IL-17F, IL-6, IL-22, and tumor necrosis factor α (TNF-α).”
BackgroundInfluentialSurface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells
Acosta-Rodriguez, E. V., Rivino, L., Geginat, J., Jarrossay, D., Gattorno, M., Lanzavecchia, A., Sallusto, F., & Napolitani, G. (2007) · Nature Immunology · doi:10.1038/ni1467 · Cited by 1,828 · cited 1×
“Subsequently, Th17 subset was identified as CD4 T cells with reactivity to Candida albicans (37, 78).”
BackgroundFox, R. I. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66990-5 · Cited by 1,828
Pathogenesis and therapy of psoriasis
Lowes, M. A., Bowcock, A. M., & Krueger, J. G. (2007) · Nature · doi:10.1038/nature05663 · Cited by 1,778
Increased expression of interleukin 17 in inflammatory bowel disease
Fujino, S., Andoh, A., Bamba, S., Ogawa, A., Hata, K., Araki, Y., Bamba, T., & Fujiyama, Y. (2003) · Gut · doi:10.1136/gut.52.1.65 · Cited by 1,713
Kotake, S., Udagawa, N., Takahashi, N., Matsuzaki, K., Itoh, K., Ishiyama, S., Saito, S., Inoue, K., Kamatani, N., Gillespie, M. T., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5703 · Cited by 1,696
Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation
Murphy, C. A., Langrish, C. L., Chen, Y., Blumenschein, W., McClanahan, T., Kastelein, R. A., Sedgwick, J. D., & Cua, D. J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030896 · Cited by 1,669
Lock, C., Hermans, G., Pedotti, R., Brendolan, A., Schadt, E., Garren, H., Langer-Gould, A., Strober, S., Cannella, B., Allard, J., et al. (2002) · Nature Medicine · doi:10.1038/nm0502-500 · Cited by 1,669
Lowes, M. A., Suárez-Fariñas, M., & Krueger, J. G. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120225 · Cited by 1,650
T Helper 17 Lineage Differentiation Is Programmed by Orphan Nuclear Receptors RORα and RORγ
Yang, X. O., Pappu, B. P., Nurieva, R., Akimzhanov, A., Kang, H. S., Chung, Y., Ma, L., Shah, B., Panopoulos, A. D., Schluns, K. S., et al. (2008) · Immunity · doi:10.1016/j.immuni.2007.11.016 · Cited by 1,605 · cited 6×
“In SS, Th17 cells may be activated by dendritic cells in lymph nodes draining the salivary and lacrimal glands by the production of cytokines as TGF-β and IL-23.”
BackgroundInfluentialThe IL-23-IL-17 immune axis: from mechanisms to therapeutic testing
Gaffen, S. L., Jain, R., Garg, A. V., & Cua, D. J. (2014) · Nature reviews. Immunology · doi:10.1038/nri3707 · Cited by 1,585
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis
van der Heijde, D., Ramiro, S., Landewé, R., Baraliakos, X., Van den Bosch, F., Sepriano, A., Regel, A., Ciurea, A., Dagfinrud, H., Dougados, M., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210770 · Cited by 1,568
Sutton, C. E., Lalor, S. J., Sweeney, C. M., Brereton, C. F., Lavelle, E. C., & Mills, K. H. G. (2009) · Immunity · doi:10.1016/j.immuni.2009.08.001 · Cited by 1,553
IL-23 is essential for T cell–mediated colitis and promotes inflammation via IL-17 and IL-6
Yen, D., Cheung, J., Scheerens, H., Poulet, F., McClanahan, T., Mckenzie, B., Kleinschek, M. A., Owyang, A., Mattson, J., Blumenschein, W., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci21404 · Cited by 1,542
McGeachy, M. J., Bak-Jensen, K. S., Chen, Y., Tato, C. M., Blumenschein, W., McClanahan, T., & Cua, D. J. (2007) · Nature Immunology · doi:10.1038/ni1539 · Cited by 1,520
Interleukin-2 Signaling via STAT5 Constrains T Helper 17 Cell Generation
Laurence, A., Tato, C. M., Davidson, T. S., Kanno, Y., Chen, Z., Yao, Z., Blank, R. B., Meylan, F., Siegel, R., Hennighausen, L., et al. (2007) · Immunity · doi:10.1016/j.immuni.2007.02.009 · Cited by 1,507
Essential autocrine regulation by IL-21 in the generation of inflammatory T cells
Nurieva, R., Yang, X. O., Martinez, G., Zhang, Y., Panopoulos, A. D., Ma, L., Schluns, K., Tian, Q., Watowich, S. S., Jetten, A. M., et al. (2007) · Nature · doi:10.1038/nature05969 · Cited by 1,466
Pneumocystis Pneumonia—Los Angeles
(1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540130018007 · Cited by 1,447
Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants
Wellcome Trust Case Control Consortium, & The Australo-Anglo-American Spondylitis Consortium (TASC) (2007) · Nature Genetics · doi:10.1038/ng.2007.17 · Cited by 1,374
IL-22 Increases the Innate Immunity of Tissues
Wolk, K., Kunz, S., Witte, E., Friedrich, M., Asadullah, K., & Sabat, R. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.007 · Cited by 1,359
Parham, C., Chirica, M., Timans, J., Vaisberg, E., Travis, M., Cheung, J., Pflanz, S., Zhang, R., Singh, K. P., Vega, F., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5699 · Cited by 1,296
Manel, N., Unutmaz, D., & Littman, D. R. (2008) · Nature Immunology · doi:10.1038/ni.1610 · Cited by 1,291
Taurog, J. D., Richardson, J. A., Croft, J. T., Simmons, W. A., Zhou, M., Fernández-Sueiro, J. L., Balish, E., & Hammer, R. E. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.6.2359 · Cited by 1,156
The IL-23/Th17 Axis in the Immunopathogenesis of Psoriasis
Di Cesare, A., Di Meglio, P., & Nestle, F. O. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.59 · Cited by 1,129
McGeachy, M. J., Chen, Y., Tato, C. M., Laurence, A., Joyce-Shaikh, B., Blumenschein, W. M., McClanahan, T. K., O'Shea, J. J., & Cua, D. J. (2009) · Nature Immunology · doi:10.1038/ni.1698 · Cited by 1,074 · cited 1×
“Confirming these observations, in the absence of Il-23, Th17 cells experience “arrested development” leading to impaired function (40).”
BackgroundIL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4−CD8− entheseal resident T cells
Sherlock, J. P., Joyce-Shaikh, B., Turner, S. P., Chao, C.-C., Sathe, M., Grein, J., Gorman, D. M., Bowman, E. P., McClanahan, T. K., Yearley, J. H., et al. (2012) · Nature Medicine · doi:10.1038/nm.2817 · Cited by 1,060
Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis
Baeten, D., Sieper, J., Braun, J., Baraliakos, X., Dougados, M., Emery, P., Deodhar, A., Porter, B., Martin, R., Andersson, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1505066 · Cited by 1,029
Pivotal Role of Dermal IL-17-Producing γδ T Cells in Skin Inflammation
Cai, Y., Shen, X., Ding, C., Qi, C., Li, K., Li, X., Jala, V. R., Zhang, H.-G., Wang, T., Zheng, J., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.08.001 · Cited by 1,026
Conti, H. R., Shen, F., Nayyar, N., Stocum, E., Sun, J. N., Lindemann, M. J., Ho, A. W., Hai, J. H., Yu, J. J., Jung, J. W., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081463 · Cited by 1,024
Ferber, I. A., Brocke, S., Taylor-Edwards, C., Ridgway, W., Dinisco, C., Steinman, L., Dalton, D., & Fathman, C. G. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.1.5 · Cited by 989
Stumhofer, J. S., Laurence, A., Wilson, E. H., Huang, E., Tato, C. M., Johnson, L. M., Villarino, A. V., Huang, Q., Yoshimura, A., Sehy, D., et al. (2006) · Nature Immunology · doi:10.1038/ni1376 · Cited by 955
Schön, M. P., & Boehncke, W.-H. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041320 · Cited by 955
Wolk, K., Witte, E., Wallace, E., Döcke, W., Kunz, S., Asadullah, K., Volk, H., Sterry, W., & Sabat, R. (2006) · European Journal of Immunology · doi:10.1002/eji.200535503 · Cited by 922
Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β
Zielinski, C. E., Mele, F., Aschenbrenner, D., Jarrossay, D., Ronchi, F., Gattorno, M., Monticelli, S., Lanzavecchia, A., & Sallusto, F. (2012) · Nature · doi:10.1038/nature10957 · Cited by 919
Pneumocystis pneumonia--Los Angeles.
(1981) · PubMed · Cited by 916
Mast Cells and Neutrophils Release IL-17 through Extracellular Trap Formation in Psoriasis
Lin, A. M., Rubin, C. J., Khandpur, R., Wang, J. Y., Riblett, M., Yalavarthi, S., Villanueva, E. C., Shah, P., Kaplan, M. J., & Bruce, A. T. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100123 · Cited by 906
Ankylosing Spondylitis and Axial Spondyloarthritis
Taurog, J. D., Chhabra, A., & Colbert, R. A. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1406182 · Cited by 900
Lee, E., Trepicchio, W. L., Oestreicher, J. L., Pittman, D., Wang, F., Chamian, F., Dhodapkar, M., & Krueger, J. G. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20030451 · Cited by 899
Neutrophil Recruitment by Human IL-17 Via C-X-C Chemokine Release in the Airways
Laan, M., Cui, Z.-H., Hoshino, H., Lötvall, J., Sjöstrand, M., Gruenert, D. C., Skoogh, B.-E., & Lindén, A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.4.2347 · Cited by 880
Teng, M. W. L., Bowman, E. P., McElwee, J. J., Smyth, M. J., Casanova, J.-L., Cooper, A. M., & Cua, D. J. (2015) · Nature Medicine · doi:10.1038/nm.3895 · Cited by 873
International Genetics of Ankylosing Spondylitis Consortium (IGAS) (2013) · Nature Genetics · doi:10.1038/ng.2667 · Cited by 860
Requirement of Interleukin‐17A for Systemic Anti– Candida albicans Host Defense in Mice
Huang, W., Na, L., Fidel, P. L., & Schwarzenberger, P. (2004) · The Journal of Infectious Diseases · doi:10.1086/422329 · Cited by 859
Interleukin-17 promotes angiogenesis and tumor growth
Numasaki, M. (2003) · Blood · doi:10.1182/blood-2002-05-1461 · Cited by 834
Batten, M., Li, J., Yi, S., Kljavin, N. M., Danilenko, D. M., Lucas, S., Lee, J., de Sauvage, F. J., & Ghilardi, N. (2006) · Nature Immunology · doi:10.1038/ni1375 · Cited by 825
Crispín, J. C., Oukka, M., Bayliss, G., Cohen, R. A., Van Beek, C. A., Stillman, I. E., Kyttaris, V. C., Juang, Y.-T., & Tsokos, G. C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.12.8761 · Cited by 789
The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis
Blauvelt, A., & Chiricozzi, A. (2018) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-018-8702-3 · Cited by 789
Guidelines of care for the management of psoriasis and psoriatic arthritis
Gottlieb, A., Korman, N. J., Gordon, K. B., Feldman, S. R., Lebwohl, M., Koo, J. Y. M., Van Voorhees, A. S., Elmets, C. A., Leonardi, C. L., Beutner, K. R., et al. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.02.040 · Cited by 769
Understanding the IL-23–IL-17 immune pathway
McKenzie, B. S., Kastelein, R. A., & Cua, D. J. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.10.003 · Cited by 766
Kastelein, R. A., Hunter, C. A., & Cua, D. J. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104758 · Cited by 763
IL‐12 and IL‐23: master regulators of innate and adaptive immunity
Langrish, C. L., McKenzie, B. S., Wilson, N. J., De Waal Malefyt, R., Kastelein, R. A., & Cua, D. J. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00214.x · Cited by 753
The International IBD Genetics Consortium (IIBDGC), Ellinghaus, D., International Genetics of Ankylosing Spondylitis Consortium (IGAS), International PSC Study Group (IPSCSG), Genetic Analysis of Psoriasis Consortium (GAPC), Psoriasis Association Genetics Extension (PAGE), Jostins, L., Spain, S. L., Cortes, A., Bethune, J., et al. (2016) · Nature Genetics · doi:10.1038/ng.3528 · Cited by 751 · cited 1×
“The most relevant are located in the genes coding for IL-23R and STAT3 and TYK2, which are downstream targets of IL-23 signaling (110, 111).”
BackgroundInterleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis
Matusevicius, D., Kivisäkk, P., He, B., Kostulas, N., Özenci, V, Fredrikson, S., & Link, H. (1999) · Multiple Sclerosis Journal · doi:10.1177/135245859900500206 · Cited by 751
Possible Pathogenic Role of Th17 Cells for Atopic Dermatitis
Koga, C., Kabashima, K., Shiraishi, N., Kobayashi, M., & Tokura, Y. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.111 · Cited by 671
IL-21 Is Produced by Th17 Cells and Drives IL-17 Production in a STAT3-dependent Manner
Wei, L., Laurence, A., Elias, K. M., & O'Shea, J. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705100200 · Cited by 641
Susceptibility to ankylosing spondylitis in twins the role of genes, HLA, and the environment
Brown, M. A., Kennedy, L. G., Macgregor, A. J., Darke, C., Duncan, E., Shatford, J. L., Taylor, A., Calin, A., & Wordsworth, P. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780401015 · Cited by 627
Identification of an IL-17–producing NK1.1neg iNKT cell population involved in airway neutrophilia
Michel, M.-L., Keller, A. C., Paget, C., Fujio, M., Trottein, F., Savage, P. B., Wong, C.-H., Schneider, E., Dy, M., & Leite-de-Moraes, M. C. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061551 · Cited by 617
Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae
Happel, K. I., Dubin, P. J., Zheng, M., Ghilardi, N., Lockhart, C., Quinton, L. J., Odden, A. R., Shellito, J. E., Bagby, G. J., Nelson, S., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050193 · Cited by 605
IL-17 family: Cytokines, receptors and signaling
Gu, C., Wu, L., & Li, X. (2013) · Cytokine · doi:10.1016/j.cyto.2013.07.022 · Cited by 595
Baeten, D., Baraliakos, X., Braun, J., Sieper, J., Emery, P., van der Heijde, D., McInnes, I., van Laar, J. M., Landewé, R., Wordsworth, P., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61134-4 · Cited by 595
The pathogenesis of psoriatic arthritis
Veale, D. J., & Fearon, U. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30830-4 · Cited by 576
Interleukin 25 promotes the initiation of proallergic type 2 responses
Angkasekwinai, P., Park, H., Wang, Y.-H., Wang, Y.-H., Chang, S. H., Corry, D. B., Liu, Y.-J., Zhu, Z., & Dong, C. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061675 · Cited by 554
Proinflammatory T helper type 17 cells are effective B-cell helpers
Mitsdoerffer, M., Lee, Y., Jäger, A., Kim, H.-J., Korn, T., Kolls, J. K., Cantor, H., Bettelli, E., & Kuchroo, V. K. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009234107 · Cited by 534
Wong, C. K., Lit, L. C. W., Tam, L. S., Li, E. K. M., Wong, P. T. Y., & Lam, C. W. K. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.01.019 · Cited by 532
York, I. A., Chang, S.-C., Saric, T., Keys, J. A., Favreau, J. M., Goldberg, A. L., & Rock, K. L. (2002) · Nature Immunology · doi:10.1038/ni860 · Cited by 511
Interleukin‐17 in host defence against bacterial, mycobacterial and fungal pathogens
Curtis, M. M., & Way, S. S. (2009) · Immunology · doi:10.1111/j.1365-2567.2008.03017.x · Cited by 502
Ankylosing spondylitis: etiology, pathogenesis, and treatments
Zhu, W., He, X., Cheng, K., Zhang, L., Chen, D., Wang, X., Qiu, G., Cao, X., & Weng, X. (2019) · Bone Research · doi:10.1038/s41413-019-0057-8 · Cited by 502
Elyaman, W., Bradshaw, E. M., Uyttenhove, C., Dardalhon, V., Awasthi, A., Imitola, J., Bettelli, E., Oukka, M., van Snick, J., Renauld, J.-C., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812530106 · Cited by 498
Th17 Cell Pathway in Human Immunity: Lessons from Genetics and Therapeutic Interventions
Patel, D. D., & Kuchroo, V. K. (2015) · Immunity · doi:10.1016/j.immuni.2015.12.003 · Cited by 486
Transcriptional regulation of Th17 cell differentiation
Ivanov, I. I., Zhou, L., & Littman, D. R. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2007.10.011 · Cited by 484
Salomonsson, S., Jonsson, M. V., Skarstein, K., Brokstad, K. A., Hjelmström, P., Wahren‐Herlenius, M., & Jonsson, R. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11311 · Cited by 472
Accelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice
Vermeire, K., Heremans, H., Vandeputte, M., Huang, S., Billiau, A., & Matthys, P. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.11.5507 · Cited by 458
Genovese, M. C., Van den Bosch, F., Roberson, S. A., Bojin, S., Biagini, I. M., Ryan, P., & Sloan‐Lancaster, J. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27334 · Cited by 451
Happel, K. I., Zheng, M., Young, E., Quinton, L. J., Lockhart, E., Ramsay, A. J., Shellito, J. E., Schurr, J. R., Bagby, G. J., Nelson, S., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.9.4432 · Cited by 449
Th17 and natural Treg cell population dynamics in systemic lupus erythematosus
Yang, J., Chu, Y., Yang, X., Gao, D., Zhu, L., Yang, X., Wan, L., & Li, M. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24499 · Cited by 444
The IL-23-IL-17 axis in inflammatory arthritis
Lubberts, E. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.53 · Cited by 442
Zaba, L. C., Fuentes-Duculan, J., Eungdamrong, N. J., Abello, M. V., Novitskaya, I., Pierson, K. C., Gonzalez, J., Krueger, J. G., & Lowes, M. A. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.194 · Cited by 442
Brief Report: Intestinal Dysbiosis in Ankylosing Spondylitis
Costello, M., Ciccia, F., Willner, D., Warrington, N., Robinson, P. C., Gardiner, B., Marshall, M., Kenna, T. J., Triolo, G., & Brown, M. A. (2015) · Arthritis & Rheumatology · doi:10.1002/art.38967 · Cited by 432
Self-citationPathophysiology of psoriasis: Recent advances on IL-23 and Th17 cytokines
Fitch, E., Harper, E., Skorcheva, I., Kurtz, S. E., & Blauvelt, A. (2007) · Current Rheumatology Reports · doi:10.1007/s11926-007-0075-1 · Cited by 415
Nash, P., Kirkham, B., Okada, M., Rahman, P., Combe, B., Burmester, G.-R., Adams, D. H., Kerr, L., Lee, C., Shuler, C. L., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31429-0 · Cited by 405
DeLay, M. L., Turner, M. J., Klenk, E. I., Smith, J. A., Sowders, D. P., & Colbert, R. A. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24763 · Cited by 404
Shivakumar, S., Tsokos, G. C., & Datta, S. K. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.1.103 · Cited by 402
Rachitskaya, A. V., Hansen, A. M., Horai, R., Li, Z., Villasmil, R., Luger, D., Nussenblatt, R. B., & Caspi, R. R. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.8.5167 · Cited by 399
Baeten, D., Østergaard, M., Wei, J. C.-C., Sieper, J., Järvinen, P., Tam, L.-S., Salvarani, C., Kim, T.-H., Solinger, A., Datsenko, Y., et al. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-213328 · Cited by 390
Shalom-Barak, T., Quach, J., & Lotz, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.42.27467 · Cited by 388
Villanova, F., Flutter, B., Tosi, I., Grys, K., Sreeneebus, H., Perera, G. K., Chapman, A., Smith, C. H., Di Meglio, P., & Nestle, F. O. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.477 · Cited by 386
Jandus, C., Bioley, G., Rivals, J., Dudler, J., Speiser, D., & Romero, P. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23655 · Cited by 382
van der Heijde, D., Deodhar, A., Wei, J. C., Drescher, E., Fleishaker, D., Hendrikx, T., Li, D., Menon, S., & Kanik, K. S. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210322 · Cited by 376
Ruddy, M. J., Wong, G. C., Liu, X. K., Yamamoto, H., Kasayama, S., Kirkwood, K. L., & Gaffen, S. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308809200 · Cited by 364 · cited 1×
“IL-17 works in synergy with TNF-α causing release of the IL-6, TNF-α, and IL-1β, in order to amplify the multifaceted and complex inflammatory process (88).”
BackgroundCutting Edge: IL-23 Receptor GFP Reporter Mice Reveal Distinct Populations of IL-17-Producing Cells
Awasthi, A., Riol-Blanco, L., Jäger, A., Korn, T., Pot, C., Galileos, G., Bettelli, E., Kuchroo, V. K., & Oukka, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900732 · Cited by 364
Distinct regulation of interleukin‐17 in human T helper lymphocytes
Chen, Z., Tato, C. M., Muul, L., Laurence, A., & O'Shea, J. J. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22866 · Cited by 358
van der Heijde, D., Song, I.-H., Pangan, A. L., Deodhar, A., van den Bosch, F., Maksymowych, W. P., Kim, T.-H., Kishimoto, M., Everding, A., Sui, Y., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32534-6 · Cited by 357
High susceptibility to collagen-induced arthritis in mice lacking IFN-gamma receptors
Manoury-Schwartz, B., Chiocchia, G., Bessis, N., Abehsira-Amar, O., Batteux, F., Muller, S., Huang, S., Boissier, M. C., & Fournier, C. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.11.5501 · Cited by 355
Fox, R. I., Michelson, P., Casiano, C. A., Hayashi, J., & Stern, M. (2000) · Clinics in Dermatology · doi:10.1016/s0738-081x(00)00135-8 · Cited by 355
Mease, P. J., Rahman, P., Gottlieb, A. B., Kollmeier, A. P., Hsia, E. C., Xu, X. L., Sheng, S., Agarwal, P., Zhou, B., Zhuang, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30263-4 · Cited by 355
van Hamburg, J. P., Asmawidjaja, P. S., Davelaar, N., Mus, A. M. C., Colin, E. M., Hazes, J. M. W., Dolhain, R. J. E. M., & Lubberts, E. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30093 · Cited by 341
Ciccia, F., Guggino, G., Rizzo, A., Alessandro, R., Luchetti, M. M., Milling, S., Saieva, L., Cypers, H., Stampone, T., Di Benedetto, P., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210000 · Cited by 338
Self-citationRuiz de Morales, J. M. G., Puig, L., Daudén, E., Cañete, J. D., Pablos, J. L., Martín, A. O., Juanatey, C. G., Adán, A., Montalbán, X., Borruel, N., et al. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2019.102429 · Cited by 338
Interleukin‐23: as a drug target for autoimmune inflammatory diseases
Tang, C., Chen, S., Qian, H., & Huang, W. (2012) · Immunology · doi:10.1111/j.1365-2567.2011.03522.x · Cited by 337
Teunissen, M. B. M., Munneke, J. M., Bernink, J. H., Spuls, P. I., Res, P. C. M., te Velde, A., Cheuk, S., Brouwer, M. W. D., Menting, S. P., Eidsmo, L., et al. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.146 · Cited by 335
Kreymborg, K., Etzensperger, R., Dumoutier, L., Haak, S., Rebollo, A., Buch, T., Heppner, F. L., Renauld, J.-C., & Becher, B. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.12.8098 · Cited by 333
Starnes, T., Broxmeyer, H. E., Robertson, M. J., & Hromas, R. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.2.642 · Cited by 331
van Vollenhoven, R. F., Hahn, B. H., Tsokos, G. C., Wagner, C. L., Lipsky, P., Touma, Z., Werth, V. P., Gordon, R. M., Zhou, B., Hsu, B., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32167-6 · Cited by 330
γδ T cells: an important source of IL-17
Roark, C. L., Simonian, P. L., Fontenot, A. P., Born, W. K., & O’Brien, R. L. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.03.006 · Cited by 325
Ciccia, F., Guggino, G., Rizzo, A., Saieva, L., Peralta, S., Giardina, A., Cannizzaro, A., Sireci, G., De Leo, G., Alessandro, R., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206323 · Cited by 312
Self-citationKatsifis, G. E., Rekka, S., Moutsopoulos, N. M., Pillemer, S., & Wahl, S. M. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.090319 · Cited by 310
Cortes, A., Pulit, S. L., Leo, P. J., Pointon, J. J., Robinson, P. C., Weisman, M. H., Ward, M., Gensler, L. S., Zhou, X., Garchon, H.-J., et al. (2015) · Nature Communications · doi:10.1038/ncomms8146 · Cited by 306
The IL-23/Th17 axis: therapeutic targets for autoimmune inflammation
Kikly, K., Liu, L., Na, S., & Sedgwick, J. D. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.09.008 · Cited by 303
Zaba, L. C., Suárez-Fariñas, M., Fuentes-Duculan, J., Nograles, K. E., Guttman-Yassky, E., Cardinale, I., Lowes, M. A., & Krueger, J. G. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.08.046 · Cited by 303
IL-17–Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicans
Conti, H. R., & Gaffen, S. L. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500909 · Cited by 301
Genovese, M. C., Durez, P., Richards, H. B., Supronik, J., Dokoupilova, E., Mazurov, V., Aelion, J. A., Lee, S.-H., Codding, C. E., Kellner, H., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201601 · Cited by 293
Nguyen, C. Q., Hu, M. H., Li, Y., Stewart, C., & Peck, A. B. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23214 · Cited by 290
Genetics of ankylosing spondylitis—insights into pathogenesis
Brown, M. A., Kenna, T., & Wordsworth, B. P. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.133 · Cited by 289
Microscopic gut inflammation in axial spondyloarthritis: a multiparametric predictive model
Van Praet, L., Van den Bosch, F. E., Jacques, P., Carron, P., Jans, L., Colman, R., Glorieus, E., Peeters, H., Mielants, H., De Vos, M., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202135 · Cited by 289
IL-22 Is Required for Imiquimod-Induced Psoriasiform Skin Inflammation in Mice
Van Belle, A. B., de Heusch, M., Lemaire, M. M., Hendrickx, E., Warnier, G., Dunussi-Joannopoulos, K., Fouser, L. A., Renauld, J.-C., & Dumoutier, L. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102224 · Cited by 287
Huber, M., Brüstle, A., Reinhard, K., Guralnik, A., Walter, G., Mahiny, A., von Löw, E., & Lohoff, M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809077106 · Cited by 282
CONTRIBUTION OF INTERLEUKIN 17 TO SYNOVIUM MATRIX DESTRUCTION IN RHEUMATOID ARTHRITIS
Chabaud, M., Garnero, P., Dayer, J.-M., Guerne, P.-A., Fossiez, F., & Miossec, P. (2000) · Cytokine · doi:10.1006/cyto.2000.0681 · Cited by 277
Petermann, F., Rothhammer, V., Claussen, M. C., Haas, J. D., Blanco, L. R., Heink, S., Prinz, I., Hemmer, B., Kuchroo, V. K., Oukka, M., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.08.013 · Cited by 275
Interleukin‐17–positive mast cells contribute to synovial inflammation in spondylarthritis
Noordenbos, T., Yeremenko, N., Gofita, I., van de Sande, M., Tak, P. P., Caňete, J. D., & Baeten, D. (2012) · Arthritis & Rheumatism · doi:10.1002/art.33396 · Cited by 270
Th17 cells in inflammation and autoimmunity
Singh, R. P., Hasan, S., Sharma, S., Nagra, S., Yamaguchi, D. T., Wong, D. T. W., Hahn, B. H., & Hossain, A. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.08.019 · Cited by 266
Di Meglio, P., Di Cesare, A., Laggner, U., Chu, C.-C., Napolitano, L., Villanova, F., Tosi, I., Capon, F., Trembath, R. C., Peris, K., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017160 · Cited by 262
Kenna, T. J., Davidson, S. I., Duan, R., Bradbury, L. A., McFarlane, J., Smith, M., Weedon, H., Street, S., Thomas, R., Thomas, G. P., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.33507 · Cited by 262
Poddubnyy, D., Hermann, K.-G. A., Callhoff, J., Listing, J., & Sieper, J. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204248 · Cited by 260
Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome
Voulgarelis, M., & Tzioufas, A. G. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.118 · Cited by 259
Th17 and Th22 cells in psoriatic arthritis and psoriasis
Benham, H., Norris, P., Goodall, J., Wechalekar, M. D., FitzGerald, O., Szentpetery, A., Smith, M., Thomas, R., & Gaston, H. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4317 · Cited by 253
HLA-B27 Misfolding in Transgenic Rats Is Associated with Activation of the Unfolded Protein Response
Turner, M. J., Sowders, D. P., DeLay, M. L., Mohapatra, R., Bai, S., Smith, J. A., Brandewie, J. R., Taurog, J. D., & Colbert, R. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.4.2438 · Cited by 246
van der Heijde, D., Baraliakos, X., Gensler, L. S., Maksymowych, W. P., Tseluyko, V., Nadashkevich, O., Abi-Saab, W., Tasset, C., Meuleners, L., Besuyen, R., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32463-2 · Cited by 242
Ciccia, F., Bombardieri, M., Principato, A., Giardina, A., Tripodo, C., Porcasi, R., Peralta, S., Franco, V., Giardina, E., Craxi, A., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24389 · Cited by 241
Self-citationTaurog, J. D., Maika, S. D., Simmons, W. A., Breban, M., & Hammer, R. E. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.9.4168 · Cited by 239
Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis
Mei, Y., Pan, F., Gao, J., Ge, R., Duan, Z., Zeng, Z., Liao, F., Xia, G., Wang, S., Xu, S., et al. (2011) · Clinical Rheumatology · doi:10.1007/s10067-010-1647-4 · Cited by 236
Wakita, D., Sumida, K., Iwakura, Y., Nishikawa, H., Ohkuri, T., Chamoto, K., Kitamura, H., & Nishimura, T. (2010) · European Journal of Immunology · doi:10.1002/eji.200940157 · Cited by 236
Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion
Chizzolini, C., Chicheportiche, R., Alvarez, M., de Rham, C., Roux-Lombard, P., Ferrari-Lacraz, S., & Dayer, J.-M. (2008) · Blood · doi:10.1182/blood-2008-05-155408 · Cited by 235
IL-23 and IL-12 Have Overlapping, but Distinct, Effects on Murine Dendritic Cells
Belladonna, M. L., Renauld, J.-C., Bianchi, R., Vacca, C., Fallarino, F., Orabona, C., Fioretti, M. C., Grohmann, U., & Puccetti, P. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5448 · Cited by 233
TH17 cells promote microbial killing and innate immune sensing of DNA via interleukin 26
Meller, S., Di Domizio, J., Voo, K. S., Friedrich, H. C., Chamilos, G., Ganguly, D., Conrad, C., Gregorio, J., Le Roy, D., Roger, T., et al. (2015) · Nature Immunology · doi:10.1038/ni.3211 · Cited by 231
HLA-B27 misfolding and ankylosing spondylitis
Colbert, R. A., Tran, T. M., & Layh-Schmitt, G. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2013.07.013 · Cited by 228
Kleinschek, M. A., Muller, U., Brodie, S. J., Stenzel, W., Kohler, G., Blumenschein, W. M., Straubinger, R. K., McClanahan, T., Kastelein, R. A., & Alber, G. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.2.1098 · Cited by 227
Boutet, M.-A., Nerviani, A., Gallo Afflitto, G., & Pitzalis, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020530 · Cited by 226
Deodhar, A., van der Heijde, D., Gensler, L. S., Kim, T.-H., Maksymowych, W. P., Østergaard, M., Poddubnyy, D., Marzo-Ortega, H., Bessette, L., Tomita, T., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(19)32971-x · Cited by 218
Genovese, M. C., Greenwald, M., Cho, C., Berman, A., Jin, L., Cameron, G. S., Benichou, O., Xie, L., Braun, D., Berclaz, P., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38617 · Cited by 211 · cited 1×
“This improvement was confirmed in a phase II study in which Ixekizumab was administered to patients who were naive to biological therapy or resistant to TNF-α inhibitors (217).”
ResultCompromised Humoral and Delayed-Type Hypersensitivity Responses in IL-23-Deficient Mice
Ghilardi, N., Kljavin, N., Chen, Q., Lucas, S., Gurney, A. L., & de Sauvage, F. J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.2827 · Cited by 206
Chan, A. T., Kollnberger, S. D., Wedderburn, L. R., & Bowness, P. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21395 · Cited by 203
Heinlen, L. D., McClain, M. T., Merrill, J., Akbarali, Y. W., Edgerton, C. C., Harley, J. B., & James, J. A. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22665 · Cited by 202
Th17 cells play a critical role in the development of experimental Sjögren’s syndrome
Lin, X., Rui, K., Deng, J., Tian, J., Wang, X., Wang, S., Ko, K.-H., Jiao, Z., Chan, V. S.-F., Lau, C. S., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204584 · Cited by 198
Yago, T., Nanke, Y., Ichikawa, N., Kobashigawa, T., Mogi, M., Kamatani, N., & Kotake, S. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22326 · Cited by 197
Role of HLA-B27 in the pathogenesis of ankylosing spondylitis
Chen, B., Li, J., He, C., Li, D., Tong, W., Zou, Y., & Xu, W. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6248 · Cited by 191
Association of interleukin‐23 receptor variants with ankylosing spondylitis
Rahman, P., Inman, R. D., Gladman, D. D., Reeve, J. P., Peddle, L., & Maksymowych, W. P. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23389 · Cited by 181
How microorganisms tip the balance between interleukin-12 family members
Goriely, S., Neurath, M. F., & Goldman, M. (2008) · Nature Reviews Immunology · doi:10.1038/nri2225 · Cited by 179
Jovanović, D., Martel‐Pelletier, J., Battista, J. A. D., Mineau, F., Jolicoeur, F. C., Benderdour, M., & Pelletier, J. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200005)43:5<1134::aid-anr24>3.0.co;2-# · Cited by 170
Doisne, J.-M., Becourt, C., Amniai, L., Duarte, N., Le Luduec, J.-B., Eberl, G., & Benlagha, K. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901059 · Cited by 168
van Baarsen, L. G. M., Lebre, M. C., van der Coelen, D., Aarrass, S., Tang, M. W., Ramwadhdoebé, T. H., Gerlag, D. M., & Tak, P. P. (2014) · Arthritis Research & Therapy · doi:10.1186/s13075-014-0426-z · Cited by 168
Cuthbert, R. J., Watad, A., Fragkakis, E. M., Dunsmuir, R., Loughenbury, P., Khan, A., Millner, P. A., Davison, A., Marzo-Ortega, H., Newton, D., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-215210 · Cited by 166
Melis, L., Vandooren, B., Kruithof, E., Jacques, P., Vos, M. D., Mielants, H., Verbruggen, G., Keyser, F. D., & Elewaut, D. S. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.107649 · Cited by 165
The role and modulation of CCR6+ Th17 cell populations in rheumatoid arthritis
Paulissen, S. M. J., van Hamburg, J. P., Dankers, W., & Lubberts, E. (2015) · Cytokine · doi:10.1016/j.cyto.2015.02.002 · Cited by 158
Smolen, J. S., Agarwal, S. K., Ilivanova, E. P., Xu, X. L., Ye, M., Zhuang, Y., Nnane, I. P., Radziszewski, W., Greenspan, A. J., Beutler, A. M., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209831 · Cited by 157
The potential role of Th17 cells and Th17-related cytokines in the pathogenesis of lupus nephritis
Dy, C., Chen, Y.-M., Wen, M.-C., Hsieh, T.-Y., Hung, W. T., & Lan, J.-L. (2012) · Lupus · doi:10.1177/0961203312457718 · Cited by 154
The Role of the IL-23/IL-17 Pathway in the Pathogenesis of Spondyloarthritis
Tsukazaki, H., & Kaito, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176401 · Cited by 152
Clinical associations of serum interleukin-17 in systemic lupus erythematosus
Vincent, F. B., Northcott, M., Hoi, A. Y.-B., Mackay, F., & Morand, E. F. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4277 · Cited by 149
McInnes, I. B., Mease, P. J., Ritchlin, C. T., Rahman, P., Gottlieb, A. B., Kirkham, B. W., Kajekar, R., Delicha, E.-M., Pricop, L., & Mpofu, S. (2017) · Lara D. Veeken · doi:10.1093/rheumatology/kex301 · Cited by 148
Ectopic lymphoid neogenesis in psoriatic arthritis
Cañete, J. D. D., Santiago, B., Cantaert, T., Sanmartí, R., Palacín, A., Celis, R., Graell, E., Gil-Torregrosa, B., Baeten, D., & Pablos, J. L. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.062042 · Cited by 145
Shin, H. C. K., Benbernou, N., Esnault, S. J., & Guenounou, M. (1999) · Cytokine · doi:10.1006/cyto.1998.0433 · Cited by 143
Praet, L. V., Jans, L. B. O., Carron, P., Jacques, P., Glorieus, E., Colman, R., Cypers, H., Mielants, H., Vos, M. D., Cuvelier, C. A., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203854 · Cited by 141
Are psoriasis and psoriatic arthritis the same disease? The IL-23/IL-17 axis data
Sakkas, L. I., & Bogdanos, D. P. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.09.015 · Cited by 141
Zou, J., Presky, D. H., Wu, C.-Y., & Gubler, U. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.9.6073 · Cited by 140
Felten, R., Devauchelle‐Pensec, V., Séror, R., Duffau, P., Saadoun, D., HACHULLA, E., Hatron, P., Salliot, C., Perdriger, A., Morel, J., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-218467 · Cited by 137
van der Heijde, D. M. F. M., Gensler, L. S., Deodhar, A. A., Baraliakos, X., Poddubnyy, D., Kivitz, A., Farmer, M. K., Baeten, D., Goldammer, N., Coarse, J., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-216980 · Cited by 135
Kopp, T., Lenz, P., Bello-Fernández, C., Kastelein, R. A., Kupper, T. S., & Stingl, G. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.11.5438 · Cited by 133
Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in ankylosing spondylitis
Pathan, E., Abraham, S., Rossen, E. V., Withrington, R. H., Keat, A., Charles, P. J., Paterson, E., Chowdhury, M., McClinton, C., & Taylor, P. C. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201915 · Cited by 128
Paulissen, S. M. J., van Hamburg, J. P., Davelaar, N., Asmawidjaja, P. S., Hazes, J. M. W., & Lubberts, E. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300274 · Cited by 123
Miao, M., Hao, Z., Guo, Y., Zhang, X., Zhang, S., Luo, J., Zhao, X., Zhang, C., Liu, X., Wu, X., et al. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-213036 · Cited by 120
The Early Phases of Ankylosing Spondylitis: Emerging Insights From Clinical and Basic Science
Watad, ., Bridgewood, C., Russell, T., Marzo‐Ortega, H., Cuthbert, R., & McGonagle, D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02668 · Cited by 118
Alunno, A., Bistoni, O., Bartoloni, E., Caterbi, S., Bigerna, B., Tabarrini, A., Mannucci, R., Falini, B., & Gerli, R. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201511 · Cited by 117
Structural Basis for the Dual Recognition of IL-12 and IL-23 by Ustekinumab
Luo, J., Wu, S., Lacy, E. R., Orlovsky, Y. I., Baker, A. E., Teplyakov, A., Obmolova, G., Heavner, G. A., Richter, H.-T., & Benson, J. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.07.046 · Cited by 112
IL-23 Receptor Regulates Unconventional IL-17–Producing T Cells That Control Bacterial Infections
Riol-Blanco, L., Lazarevic, V., Awasthi, A., Mitsdoerffer, M., Wilson, B. S., Croxford, A., Waisman, A., Kuchroo, V. K., Glimcher, L. H., & Oukka, M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902796 · Cited by 112
IL-23 Is Required for Protection against Systemic Infection with Listeria monocytogenes
Meeks, K. D., Sieve, A. N., Kolls, J. K., Ghilardi, N., & Berg, R. E. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901588 · Cited by 110
Martin, D. A., Churchill, M., Flores-Suarez, L. F., Cardiel, M. H., Wallace, D., Martin, R., Phillips, K., Kaine, J. L., Dong, H., Salinger, D., et al. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4347 · Cited by 107
Analysis of Th17-associated cytokines and clinical correlations in patients with dry eye disease
Liu, R., Gao, C., Chen, H., Li, Y., Jin, Y., & Qi, H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173301 · Cited by 107
Penatti, A. E., Facciotti, F., Matteis, R. D., Larghi, P., Paroni, M., Murgo, A., Lucia, O. D., Pagani, M., Pierannunzii, L., Truzzi, M. C., et al. (2017) · Arthritis Research & Therapy · doi:10.1186/s13075-017-1305-1 · Cited by 107
Marzo‐Ortega, H., Sieper, J., Kivitz, A., Blanco, R., Cohen, M., Martin, R., Readie, A., Richards, H., Porter, B. O., & on behalf of the Measure 2 Study Group (2017) · Arthritis Care & Research · doi:10.1002/acr.23233 · Cited by 105
Mease, P. J., Genovese, M. C., Weinblatt, M. E., Peloso, P. M. J., Chen, K., Othman, M. I. A., Li, Y., Mansikka, H. T., Khatri, A., Wishart, N., et al. (2018) · Arthritis & Rheumatology · doi:10.1002/art.40579 · Cited by 104
Lebwohl, M., Emer, J. J., & Koutruba, N. (2010) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s5599 · Cited by 102
Cited by
The Role of M1/M2 Macrophage Polarization in Rheumatoid Arthritis Synovitis
Cutolo, M., Campitiello, R., Gotelli, E., & Soldano, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.867260 · Cited by 631
Psoriatic Arthritis: Pathogenesis and Targeted Therapies
Azuaga, A. B., Ramírez, J., & Cañete, J. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054901 · Cited by 190
“On the other hand, a variety of innate cells, including MAIT, ILC3, iNKT, and γδ T cells, can produce IL-17 in an IL-23-independent manner [146,147], implicating them in disease pathogenesis.”
BackgroundGe, L., Liu, S., Li, S., Yang, J., Hu, G., Xu, C., & Song, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1016578 · Cited by 187
Metadata
- Authors
- Schinocca, C., Rizzo, C., Fasano, S., Grasso, G., La Barbera, L., Ciccia, F., & Guggino, G.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2021-02-22
- Volume
- 12
- Pages
- 637829-637829
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W3132820286
- Cited by
- 360
- References
- 244
- FWCI
- 17.18
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.